Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAthelney Tst. Regulatory News (ATY)

Share Price Information for Athelney Tst. (ATY)

Share Price is delayed by 15 minutes
Get Live Data
165.00    0.00 (0.00%)
Bid:
140.00
Ask:
190.00
Spread: 50.00 (35.714%)
Market Cap: £3.56m
ATY Live PriceLast checked at - London Stock Exchange

Intraday Athelney Tst. Share Chart

Net Asset Value(s)

6 Jan 2025 10:25

RNS Number : 2576S
Athelney Trust PLC
06 January 2025
 

Athelney Trust PLC

 

Legal Entity Identifier:

213800ON67TJC7F4DL05

The unaudited net asset value of Athelney Trust was 186.1p at 31 December 2024.

Fund Manager's comment for December 2024

The U.S. Federal Reserve announced a 25-basis point cut to the federal funds rate in December, marking it the third consecutive reduction in 2024 and which brought borrowing costs down to a range of 4.25% - 4.5%, in line with market expectations. The Fed also revised its GDP growth projections upward, now expecting 2.5% growth in 2024 (up from 2%) and 2.1% in 2025 (up from 2%), while maintaining a 2% outlook for 2026.

The U.S. economy grew at an annualised rate of 3.1% in Q3 2024, an improvement over the estimate of 2.8%. Consumer spending accelerated at its fastest pace since Q1 2023, fuelled by a 5.6% rise in goods consumption and robust spending on services. Fixed investment also exceeded expectations, increasing by 2.1% versus a forecasted 1.7%.

However, the manufacturing sector face numerous headwinds with the U.S. Manufacturing PMI dropping to 48.3 from 49.7 in November, well short of market expectations and signalling persistent contraction. New orders continued to decline, pushing production to its lowest level since August 2009, excluding the pandemic disruptions of Q2 2020. In contrast, the U.S. Services sector delivered a positive surprise with the Services PMI climbing to 58.5 from 56.1 in November, reflecting the strongest growth in over two years. This was driven by rising new orders and improved confidence tied to expectations of business-friendly policies under the Trump administration.

In the Eurozone, Q3 2024 GDP expanded by 0.4% compared to the previous quarter. However, the manufacturing sector continued to struggle, with the Manufacturing PMI remaining unchanged in December. This marks two years of consecutive monthly contractions, driven by a sustained decline in new orders and the steepest output reductions since 2023.

On a positive note, the Eurozone services sector also showed resilience, with the Services PMI rising to 51.4 in December from 49.5 in November. This unexpected recovery marked a return to expansion, supported by improving optimism about the 12-month outlook for output.

In the UK. the economy remained subdued, with GDP growth stalling in Q3 2024. Revised data showed no growth, down from an initial estimate of 0.1%. The UK Services PMI improved to 51.4 in December from a 13-month low of 50.8 in November, exceeding expectations. This reflected modest growth driven by increased business activity and reduced backlogs. However, service providers expressed concerns about rising costs, including higher National Insurance contributions, which weighed on sentiment and expansion plans.

The UK manufacturing sector saw further decline, with the Manufacturing PMI falling to 47.3 from 48 in November, marking the sharpest contraction in 11 months. Production dropped for the second consecutive month as new orders declined at an accelerated rate.

In December, global equity markets saw a mixed performance. The MSCI World Index fell by 2.69%, as did the S&P 500, declining by 2.50%. The Nasdaq bucked the trend, increasing by 0.48%. In the UK, the FTSE 100 fell by 1.38% while the broader market as represented by the FTSE250 declining by 0.57%. The smaller companies were mixed with the Small Cap Index rising 0.61%, the Fledgling Index up 1.87% while the AIM All-Share Index struggled and was down by 1.76%.

Our portfolio's net asset value (NAV) decreased by 0.75%. Notable contributors to performance included Raspberry Pi, Treatt, Wise, and Alpha Group, each gaining over 5% during the month. Impax Asset Management was the largest detractor to performance, impacted by the loss of a large mandate. We reduced our holdings in Gamma Communications and increased our position in AJ Bell. At month-end, cash holdings comprised 2.5% of the portfolio.

Fact Sheet

An accompanying fact sheet which includes the information above as well as wider details on the portfolio can be found on the Fund's website www.athelneytrust.co.uk under "About" then select "Latest Monthly Fact Sheet".

Background Information

Dr. Emmanuel (Manny) Pohl AM

Manny is Chairman and Chief Investment Officer of E C Pohl & Co ("ECP"), an investment management company and has been a major shareholder in Athelney trust for many years.

E C Pohl & co is licensed by the Australian Financial services (license no.421704).

www.ecpohl.com

www.ecpam.com

Manny Pohl and the ECP group has AUD2.7bn (£1.5 billion) under its management including four listed investment companies, three listed in Australia and one in the UK:

· Flagship Investments (ASX code:FSI)

AUD95m https://flagshipinvestments.com.au

· Barrack St Investments (ASX code: BST)

AUD37m www.barrackst.com

· Global Masters Fund Limited (ASX code: GFL)

AUD33m www.globalmastersfund.com.au

· Athelney Trust plc (LSE code: ATY)

GBP6m www.athelneytrust.co.uk

Athelney Trust plc Investment Policy

 The investment objective of the Trust is to provide shareholders with prospects of long-term capital growth with the risks inherent in small cap investment minimised through a spread of holdings in quality small cap companies that operate in various industries and sectors. The Fund Manager also considers that it is important to maintain a progressive dividend record.

The assets of the Trust are allocated predominantly to companies with either a full listing on the London Stock Exchange or a trading facility on AIM or ISDX. The assets of the Trust have been allocated in two main ways: first, to the shares of those companies which have grown steadily over the years in terms of profits and dividends but, despite this progress, the market rating is favourable when compared to future earnings and dividends; second, to those companies whose shares are standing at a favourable level compared with the value of land, buildings or cash in the balance sheet.

Athelney Trust was founded in 1994. In 1996 it was one of the ten pioneer members of the Alternative Investment Market ("AIM"). In 2008 the shares became fully listed on the main market of the London Stock Exchange. Athelney Trust has a successful progressive dividend growth record and the dividend has grown every year since 2004. According to the Association of Investment Companies (AIC) Athelney Trust is a "Dividend Hero" being one of only a few investment companies that have increased their dividend every year for 20 years or more. See link

https://www.theaic.co.uk/income-finder/dividend-heroes

Website

www.athelneytrust.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVBGGDBUDGDGUL
Date   Source Headline
3rd Jun 20267:22 amRNSNet Asset Value(s)
6th May 20267:35 amRNSNet Asset Value(s)
16th Apr 20268:50 amRNSAGM Statement
7th Apr 20267:00 amRNSNet Asset Value(s)
3rd Mar 20263:15 pmRNSAnnual Financial Report
3rd Mar 202612:09 pmRNSNet Asset Value(s)
3rd Feb 20268:27 amRNSNet Asset Value(s)
5th Jan 20269:53 amRNSNet Asset Value(s)
2nd Dec 202510:41 amRNSNet Asset Value(s)
4th Nov 202511:01 amRNSNet Asset Value(s)
10th Oct 20252:27 pmRNSAuditor change
9th Oct 20254:08 pmRNSNet Asset Value(s)
3rd Oct 20257:02 amRNSNet Asset Value(s)
2nd Sep 20259:09 amRNSNet Asset Value(s)
4th Aug 202510:48 amRNSNet Asset Value(s)
25th Jul 20257:00 amRNSHalf-year Report
3rd Jul 20257:00 amRNSNet Asset Value(s)
3rd Jun 202512:08 pmRNSNet Asset Value(s)
6th May 20258:59 amRNSNet Asset Value(s)
24th Apr 20257:11 amRNSResult of the AGM
2nd Apr 20259:38 amRNSNet Asset Value(s)
11th Mar 20254:15 pmRNSAnnual Financial Report
4th Mar 202512:03 pmRNSNet Asset Value(s)
5th Feb 20258:01 amRNSNet Asset Value(s)
6th Jan 202510:25 amRNSNet Asset Value(s)
3rd Dec 20248:21 amRNSNet Asset Value(s)
4th Nov 20247:53 amRNSNet Asset Value(s)
10th Oct 20248:13 amRNSAuditor Appointment
3rd Oct 20241:29 pmRNSNet Asset Value(s)
4th Sep 20249:46 amRNSNet Asset Value(s)
16th Aug 20242:21 pmRNSChange of Adviser
2nd Aug 20247:46 amRNSNet Asset Value(s)
24th Jul 20242:03 pmRNSHalf-year Report
2nd Jul 202411:59 amRNSNet Asset Value(s)
6th Jun 20247:00 amRNSNet Asset Value(s)
7th May 20249:54 amRNSNet Asset Value(s)
4th Apr 20249:21 amRNSNet Asset Value(s)
22nd Mar 20248:15 amRNSAGM Statement
5th Mar 20242:04 pmRNSNet Asset Value(s)
13th Feb 202411:58 amRNSDividend Declaration
5th Feb 202410:17 amRNSNet Asset Value(s)
3rd Jan 202411:13 amRNSNet Asset Value(s)
5th Dec 20232:45 pmRNSNet Asset Value(s)
6th Nov 20237:00 amRNSNet Asset Value(s)
20th Oct 20237:29 amRNSAuditor appointment
10th Oct 202310:54 amRNSChange of Adviser
4th Oct 20232:58 pmRNSNet Asset Value(s)
4th Sep 202311:17 amRNSNet Asset Value(s)
2nd Aug 20239:06 amRNSNet Asset Value(s)
25th Jul 202311:37 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.